Janney Montgomery Scott Downgrades Cerulean Pharma (CERU) to Neutral

August 18, 2016 6:32 AM EDT
Get Alerts CERU Hot Sheet
Price: $0.71 +4.41%

Rating Summary:
    3 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade CERU Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Janney Montgomery Scott downgraded Cerulean Pharma (NASDAQ: CERU) from Buy to Neutral with a price target of $1.00 (from $6.00).

For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.

Shares of Cerulean Pharma closed at $2.74 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades

Related Entities

Janney Montgomery Scott

Add Your Comment